Rocket Lab USA Q2 EPS $(0.08) Beats $(0.10) Estimate, Sales $106.25M Beat $105.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
Rocket Lab USA (NASDAQ:RKLB) reported Q2 EPS of $(0.08), beating the $(0.10) estimate, and sales of $106.25M, surpassing the $105.46M estimate. This represents a 20% improvement in EPS and a 71.25% increase in sales year-over-year.
August 08, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rocket Lab USA (NASDAQ:RKLB) reported better-than-expected Q2 results with EPS of $(0.08) beating the $(0.10) estimate and sales of $106.25M surpassing the $105.46M estimate. This indicates a 20% improvement in EPS and a 71.25% increase in sales year-over-year.
The better-than-expected EPS and sales figures are likely to positively impact Rocket Lab USA's stock price in the short term. The significant year-over-year improvements in both EPS and sales further strengthen the positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100